Last edition
News about "Ministry of Food and Drug Safety (MFDS)"
GC Biopharma Wins IND Approval in Korea for Phase I COVID-19 mRNA Vaccine Trial
GC Biopharma has received IND approval in Korea to initiate a Phase I clinical trial of its COVID-19 mRNA vaccine, marking a key step in advancing its mRNA platform, with plans to submit a Phase II IND in the second half of 2026.
Ministry Of Food And Drug Safety (MFDS) | 24/12/2025 | By News Bureau
GC Biopharma's Anthrax Vaccine Shows Safety and Immunogenicity in Phase 2 trial
The Phase 2 clinical trial demonstrated that the anthrax vaccine by GC Biopharma elicited antibodies that neutralised the anthrax toxin at a level exceeding the pre-defined protective threshold. This finding indicates robust immunogenicity and suggests that BARYTHRAX can provide clinically meaningful protection against anthrax infection.
Ministry Of Food And Drug Safety (MFDS) | 03/11/2025 | By Dineshwori | 139
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy